Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma

Table 4

Characteristics of 98 patients for serum AREG.

	𝑛	Range of the age (years)	Mean of the age (years)
Normal controls	17	33–67	53.00
Benign liver diseases	31	26–69	50.23
Clinical stages	50	13–74	51.52
HCC I + II	20	26–63	49.30
HCC III + IV	30	13–74	52.55
Total	98	13–74	50.22

Stratifying the analysis by American Joint Committee on Cancer stage for HCC.